x
Corporate Summary

Gain Therapeutics is redefining drug discovery with its See-Tx™ target identification platform. By identifying and optimizing allosteric binding sites that have never before been targeted, Gain is unlocking new treatment options for difficult-to-treat disorders characterized by protein misfolding.

 

Presentations
March 18th, 2021

 



Press Releases
  • Mar 25 ,2021

    BETHESDA, Md., March 25, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (“Gain”) today announced the closing of its initial public offering of 3,636,364 shares of its common stock and full exercise of the underwriters’ overallotment option to purchase 545,454 additional shares of common stock, at a public offering price of $11.00 per share. The gross proceeds to Gain from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Gain, were...

    Read More >

  • Mar 18 ,2021

    BETHESDA, Md., March 18, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (“Gain”) today announced the pricing of its initial public offering of 3,636,364 shares of its common stock at a price of $11.00 per share. The shares are expected to begin trading on the Nasdaq Global Market on March 18, 2021 under the symbol “GANX.” The offering is expected to close on March 22, 2021 subject to customary closing conditions. The underwriters have a 30-day option to purchase up to an additional 545,454 shares of...

    Read More >

  • Mar 10 ,2021

    BETHESDA, Md., March 10, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (“Gain”) today announced that it has launched the roadshow for its initial public offering of shares of its common stock. Gain is offering 3,636,364 shares of its common stock. The initial public offering price is expected to be between $10.00 and $12.00 per share, before underwriting discounts and commissions. In addition, Gain expects to grant the underwriters a 30-day option to purchase up to an additional 545,454...

    Read More >

 

MORE



Stock Information
GANX



Contact IR

Company

GAIN THERAPEUTICS INC.

4800 Hampden Ln, St 200
Bethesda, MD 20814,
United State

Phone: +1 301 500 1556

Investor Relations

LifeSci Advisors, LLC

Dan Ferry
1 International Place
14th Floor
Boston, MA 02110

Phone: +1 617-430-7576
This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Alerts Sign Up

Form by ChronoForms - ChronoEngine.com